Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: tDCS Plus Varenicline for Smoking Cessation [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating the combination of transcranial direct current stimulation (tDCS) and varenicline for smoking cessation, with recruitment currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcranial Direct Current Stimulation (transcranial direct current stimulation)
  • Varenicline (varenicline)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Nicotine Dependence, Tobacco Smoking | Phase 4 | Status: RECRUITING